- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Partnering With Providers to Prevent or Delay Complications Related to Diabetes
John A. Johnson, MD, MBA: The microvascular complications of diabetes include anything from effects on [a patient’s] blood pressure, peripheral neuropathy, the ability to have abnormalities in their sensation (in their hands and feet), and blindness. Macrovascular complications include cardiovascular effects such as heart attacks, stroke, and end-stage kidney disease.
So we look at ways that we can, in a preventative approach, reduce those complications because, as we’ve seen at WellCare, in patients who don’t have access to care—either inadequate access or lack of behavioral modification in lifestyle changes—a negative impact in their outcomes is seen.
We work with the provider community to make them aware of the members that they have within their care—that are WellCare members—and [figure out] how we can partner with them and equip them with tools to enhance the care of diabetics to prevent or delay the onset of these micro- and macrovascular complications.
What It Takes to Improve Guideline-Based Heart Failure Care With Ty J. Gluckman, MD
August 5th 2025Explore innovative strategies to enhance heart failure treatment through guideline-directed medical therapy, remote monitoring, and artificial intelligence–driven solutions for better patient outcomes.
Listen
Semaglutide Linked to Cardiovascular Gains, but Also Higher Health Spending
August 8th 2025A real-world study found that semaglutide prescriptions were associated with improvements in weight, blood pressure, and cholesterol, but also a $80 monthly rise in health care spending outside of drug costs.
Read More
Immune Checkpoint Inhibitors More Effective vs Bevacizumab in Nonsquamous NSCLC
August 6th 2025Bevacizumab combined with chemotherapy was not as effective in advanced driver gene-negative nonsquamous non–small cell lung cancer (NSCLC) compared with immune checkpoint inhibitors plus chemotherapy.
Read More
